UCHL1 and Alzheimer disease: Although its role as a plasma biomarker in AD remains unconfirmed, UCH-L1 detection in blood has been recognized since 2018 by the Food Drug Administration (FDA) as a biomarker for mild traumatic brain injury (mTBI) [97].